Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186* signaling pathway

Oncology Reports

Volumn 24, Issue 5, 2010, Pages 1217-1223

  Zhang, Jian ^a   Du, Yongping ^a   Wu, Changgui ^a   Ren, Xinling ^a   Ti, Xinyu ^a   Shi, Jieran ^a   Zhao, Feng ^a   Yin, Hong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

A549 human lung adenocarcinoma cells; Apoptosis; Caspase 10; Curcumin; miRNA 186*

Indexed keywords

CASPASE 10; CURCUMIN; LUCIFERASE; MICRORNA; MICRORNA 186; RNA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOASSAY; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; LUNG ADENOCARCINOMA; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; REPORTER GENE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 78149342035     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000975     Document Type: Article

References (48)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin 56: 106-130, 2006.
2. Molina JR, Yang P, Cassivi SD, Schild SE and Adjei AA: Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83: 584-594, 2008.
3. Anthony HM, Madsen KE, Mason MK and Templeman GH: Lung cancer, immune status, histopathology and smoking. Is oat cell carcinoma lymphodependent? Br J Dis Chest 75: 40-54, 1981.
4. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB and Aggarwal BB: Curcumin and cancer: an 'old-age' disease with an 'age-old' solution. Cancer Lett 18: 133-364, 2008.
5. Kuttan R, Bhanumathy P, Nirmala K and George MC: Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett 29: 197-202, 1985.
6. Sandur SK, Ichikawa H, Pandey MK, et al: Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med 43: 568-580, 2007.
7. Singh S and Aggarwal BB: Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane). J Biol Chem 270: 24995-25000, 1995.
8. Hussain AR, Ahmed M, Al-Jomah NA, et al: Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Mol Cancer Ther 7: 3318-3329, 2008.
9. Mackenzie GG, Queisser N, Wolfson ML, Fraga CG, Adamo AM and Oteiza PI: Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells. Int J Cancer 123: 56-65, 2008.
10. Chadalapaka G, Jutooru I, Chintharlapalli S, et al: Curcumin decreases specificity protein expression in bladder cancer cells. Cancer Res 68: 5345-5354, 2008.
11. Lund E, Güttinger S, Calado A, Dahlberg JE and Kutay U: Nuclear export of miRNA precursors. Science 303: 95-98, 2004.
12. Kurihara Y and Watanabe Y: Arabidopsis micro-RNA biogenesis through Dicer-like 1 protein functions. Proc Natl Acad Sci USA 101: 12753-12758, 2004.
13. Roldo C, Missiaglia E, Hagan JP, et al: MiRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24: 4677-4684, 2006.
14. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S and Miyazono K: Modulation of miRNA processing by p53. Nature 460: 529-533, 2009.
15. Takamizawa J, Konishi H, Yanagisawa K, et al: Reduced expression of the let-7 miRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756, 2004.
16. Hayashita Y, Osada H, Tatematsu Y, et al: A polycistronic miRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632, 2005.
17. Wang QZ, Xu W, Habib N and Xu R: Potential uses of miRNA in lung cancer diagnosis, prognosis, and therapy. Curr Cancer Drug Targets 9: 572-594, 2009.
18. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
19. Lian J, Zhang X, Tian H, et al: Altered microRNA expression in patients with non-obstructive zoospermia. Reprod Biol Endocrinol 7: 13, 2009.
20. Chen C, Ridzon DA, Broomer AJ, et al: Real-time quantification of miRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: 179, 2005.
21. Li M, Zhang Z, Hill DL, Wang H and Zhang R: Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. Cancer Res 67: 1988-1996, 2007.
22. Schaaf C, Shan B, Buchfelder M, et al: Curcumin acts anti-tumourigenic and hormone-suppressive in murine and human pituitary tumour cells in vitro and in vivo. Endocr Relat Cancer 10: 1339-1345, 2009.
23. Zhou L, Qi X, Potashkin JA, Abdul-Karim FW and Gorodeski GI: MiRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3′-untranslated region of the gene that decrease steady-state levels of the transcript. J Biol Chem 17: 28274-28286, 2008.
24. Qin LX, Beyer RP, Hudson FN, Linford NJ, Morris DE and Kerr KF: Evaluation of methods for oligonucleotide array data via quantitative real-time PCR. BMC Bioinformatics 17: 23-28, 2006.
25. Lewis BP, Burge Cb and Bartel DP: Conserved seed paring, often flanked by adenosions, indicates that thousand of human genes are miRNA targets. Cell 120: 15-20, 2005.
26. Lim LP, Glasner ME, Yekta S, Burge CB and Bartel DP: Vertebrate miRNA genes. Science 299: 1540, 2003.
27. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH and Cuppen E: Phylogenetic shadowing and computational identification of human miRNA genes. Cell 120: 21-24, 2005.
28. Li SC, Tang P and Lin WC: Intronic miRNA: discovery and biological implications. DNA Cell Biol 26: 195-207, 2007.
29. Xia L, Zhang D, Du R, et al: miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 123: 372-379, 2008.
30. Kakar SS and Roy D: Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. Cancer Lett 87: 85-89, 1994.
31. Camacho-Barquero L, Villegas I, Sánchez-Calvo JM, et al: Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol 7: 333-342, 2007.
32. Shankar S and Srivastava RK: Involvemet of Bcl-2 famliy members, phosphatidylinositol 3′-kinase/AKT and mitochondrial p53 in curcumin(diferuloymethane)-induced apoptosis in prostate cancer. Int J Oncol 30: 905-918, 2007.
33. Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH and Kurzrock R: Curcumin (diferuoymethane) alters the expression profiles of miRNAs in human pancreatic cancer cells. Mol Cancer Ther 7: 464-743, 2008.
34. Nana-Sinkam SP and Geraci MW: MiRNA in lung cancer. J Thorac Oncol 1: 929-931, 2006.
35. Raponi M, Dossey L, Jatkoe T, et al: MiRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 69: 5776-5832, 2009.
36. Chin LJ, Ratner E, Leng S, et al: A SNP in a let-7 miRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer risk. Cancer Res 68: 8535-8540, 2008.
37. Esquela-Kerscher A, Trang P, Wiggins JF, et al: The let-7 miRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 7: 759-764, 2008.
38. Ortholan C, Puissegur MP, Ilie M, Barbry P, Mari B and Hofman P: MiRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets. Curr Med Chem 16: 1047-1061, 2009.
39. Yanaihara N, Caplen N, Bowman E, et al: Unique miRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006.
40. Giard DJ, Aaronson SA and Todaro GJ: In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51: 1417-1423, 1973.
41. Radhakrishna Pillai G, Srivastava AS, Hassanein TI, Chauhan DP and Carrier E: Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett 208: 163-170, 2004.
42. Wang J, Chun HJ, Wong W, Spencer DM and Lenardo MJ: Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci USA 98: 13884-13888, 2001.
43. Wang J, Zheng L, Lobito A, et al: Inherited human caspase-10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98: 47-58, 1999.
44. Nohara K, Yokoyama Y and Kano K: The important role of caspase-10 in sodium butyrate-induced apoptosis. Kobe J Med Sci 53: 265-273, 2007.
45. Lee HJ, Pyo JO, Oh Y, et al: AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10. Nat Cell Biol 9: 1303-1310, 2007.
46. Chen M and Wang J: Initiator caspases in apoptosis signaling pathways. Apoptosis 7: 313-319, 2002.
47. Micheau O and Tschopp J: Induction of TNF receptor Imediated apoptosis via two sequential signaling complexes. Cell 114: 181-190, 2003.
48. Xu B, Zhou ZG, Li Y, Wang L, Yang L, Zhou B, Liu HY, Song JM, Zeng YJ, Wang R, Shen XG and Sun XF: Clinicopathological significance of caspase-8 and caspase-10 expression in rectal cancer. Oncology 74: 229-236, 2008.